GLUE Form 144: 2,176 Shares From Option Exercise

GLUE submitted a Form 144 notice reporting planned and recent transactions in Common Stock.

Rhea-AI Filing Summary

GLUE submitted a Form 144 notice reporting planned and recent transactions in Common Stock. The notice lists 2,176 shares associated with an exercise of stock options and a proposed sale on 06/17/2026 for cash. It also discloses prior sales by Jennifer Champoux of 2,176 shares on 05/22/2026 and 2,175 shares on 05/27/2026, with reported amounts of $41,344.00 and $43,500.00, respectively.

Insights

Securities Counsel

Routine Rule 144 notice for option exercise and resale of common shares.

The filing lists an exercise of stock options leading to 2,176 shares intended for sale on 06/17/2026 and prior reported dispositions by Jennifer Champoux on 05/22/2026 and 05/27/2026. The transactions are reported as cash sales.

These disclosures are procedural under resale rules; cash‑flow treatment is stated as Cash. Timing and pricing mechanics beyond the dates and share counts are not provided in the excerpt, so subsequent filings would show execution details if and when they occur.

Key Figures

Planned sale from option exercise: 2,176 shares Prior sale on 05/22/2026: 2,176 shares Prior sale on 05/27/2026: 2,175 shares

3 metrics

Planned sale from option exercise 2,176 shares exercise of stock options, <date>06/17/2026</date>

Prior sale on 05/22/2026 2,176 shares disposition by Jennifer Champoux, amount listed $41,344.00

Prior sale on 05/27/2026 2,175 shares disposition by Jennifer Champoux, amount listed $43,500.00

Key Terms

Form 144, exercise of stock options, Cash

3 terms

Form 144 regulatory

"The notice lists planned and recent dispositions of restricted or control securities"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

exercise of stock options financial

"06/17/2026 | Exercise of stock options | Issuer"

Cash financial

"06/17/2026 | Exercise of stock options | Issuer | | | 2176 | 06/17/2026 | Cash"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does GLUE's Form 144 disclose about the June 17, 2026 transaction?

The Form 144 shows an exercise of stock options resulting in 2,176 shares intended for sale on 06/17/2026 for cash. The filing lists the method as an issuer option exercise leading to a resale filing.

Who reported recent sales in GLUE stock in this filing?

Jennifer Champoux is named as reporting sales of GLUE common stock of 2,176 shares on 05/22/2026 and 2,175 shares on 05/27/2026. The filing provides those share counts and dates.

What cash amounts are listed for the May 2026 sales in the Form 144?

The Form 144 lists amounts of $41,344.00 for the 05/22/2026 sale and $43,500.00 for the 05/27/2026 sale by Jennifer Champoux. These numbers appear in the sales summary.

Does the filing state how the June 17 shares will be sold?

The filing records the June 17 event as an exercise of stock options with the sales method labeled Cash. Further distribution methods or broker details are not provided in the excerpt.

Is additional disclosure required after a Form 144 is filed for these shares?

Yes. A Form 144 is a notice of intent to sell under resale rules; completion or settlement details are typically reported elsewhere, and subsequent transaction confirmations or broker reports may follow in other filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/17/2026 - 04:02 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002025233
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Monte Rosa Therapeutics, Inc.
SEC File Number	001-40522
Address of Issuer	321 HARRISON AVENUE SUITE 900 BOSTON MASSACHUSETTS 02118
Phone	617-949-2643
Name of Person for Whose Account the Securities are To Be Sold	Champoux Jennifer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	2176	39004.80	84479418	06/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/17/2026	Exercise of stock options	Issuer			2176	06/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jennifer Champoux 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118	Common	05/22/2026	2176	41344.00
Jennifer Champoux 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118	Common	05/27/2026	2175	43500.00

144: Remarks and Signature

Remarks
Date of Notice	06/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Jennifer Champoux
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)